P rotecting the rights of human subjects involved in the conduct of research is a high priority in scientific communities. Since the 1940s, ethical conduct of researchers has received increasing attention because of the mistreatment of and unethical experimentation on human subjects.
The atrocities of the Nazi medical experimentations during World War II were highly publicized. Experiments included sterilization and euthanasia of prisoners of war and also involved exposing subjects to high altitudes, freezing temperatures, bacteria, poisons, and untested drugs. Subjects had no opportunity to refuse to participate and were frequently killed or sustained permanent physical and mental damage (Institute of Society, Ethics, and the Life Sciences, 1976) . During the Nuremberg trials, these unethical research practices were made public and led to the development of the Nuremberg Code in 1949 (Levine, 1981) .
The Tuskegee Syphilis Study, conducted by the United States Public Health Service from 1932 to 1972, represented another serious violation of human rights. The purpose of the study was to determine the natural course of the disease in black males. Research subjects included 400 black males with untreated syphilis and a control group of ZOO black males without syphilis. The subjects were not informed about the purpose or procedures of the experiment.
Nurses must be aware of not only the legal parameters affecting the nurse-client relationship, but also the responsibility and accountability for the ethical protection of research subjects.
They were examined periodically, but none received treatment for syphilis, even when penicillin became available in the 1950s. In fact, not only was information about effective treatment for syphilis withheld from the subjects, but steps were taken to keep the subjects from receiving treatment (Brandt, 1978) . Not until the study received public attention was it ordered stopped in 1972 by the Department of Health, Education and Welfare (DHEW). The ethical protection of human subjects no longer is left solely to the individual investigator. In 1974, DHEW published the first set of regulations governing research involving human subjects. These regulations were viewed as very restrictive. The issue was studied extensively and in 1980 the Department of Health and Human Services (formerly DHEW) developed new regulations for the protection of human rights based on the ethical principles of autonomy, beneficence, and justice.
Human rights that must be protected include: the right to selfdetermination; the right to full disclosure; the right to confidentiality, privacy, and anonymity; the right to protection from harm; and informed consent (American Nurses' Association, 1985) .
HUMAN RIGHTS

Right to Self-Determination
An individual's right to selfdetermination is based on the ethical principle of autonomy, which is respect for persons. Embodied in this principle is the recognition that persons are not only capable of controlling their own destiny, but are autonomous agents who have the freedom to voluntarily choose to participate (or not participate) in a research study.
The use of coercion to induce subjects to participate in a research study is a violation of this right. Coercion occurs when an overt threat of harm or excessive reward is intentionally presented to a prospective subject to obtain compliance (U.S. DHHS, 1981) . For example, some workers may feel their participation in a research project is tied to their performance appraisal, while others may feel they cannot refuse excessive rewards such as large sums of money, special privileges, or promotions (Burns, 1987) .
Persons with diminished autonomy may be more vulnerable and bear special protection of their rights to self-determination. This may include children, unconscious individuals, and those with mental incapacity, illiteracy, language barriers, or institutional confinement (e.g., nursing home patients).
Right to Full Disclosure
Deception, either by withholding information about certain aspects of the study to protect its validity or by giving a subject false information, is unwarranted. Researchers have argued, however, that deceptive practices are sometimes needed, such as when knowing the full purpose of the research would either influence subjects' behavior or responses or their willingness to participate in the study.
For example, in research designed to observe work practices related to use of personal protective equipment, employees might alter their usual behavior if they are informed that such observations are occurring. In this instance, however, the researcher may need to make some adjustments in how and when observations are conducted to protect the study validity, rather than lying to the subjects. The use of deception in research violates subjects' autonomy to make informed decisions and is unethical.
Right to Confidentiality, Privacy,
and Anonymity Privacy is the right of a person to determine if private information will be withheld or disclosed to others. An invasion of privacy occurs when private information is collected under false pretenses or divulged without an individual's knowledge or consent.
Examples of private information include one's attitudes, beliefs, behaviors, opinions, diaries, and records. Information collected through surveys (questionnaires, interviews, observations, etc.) is usually private information and requires informed consent from subjects prior to data collection. Confidentiality means that information divulged by a sub-An invasion of privacy occurs when private information is collected under false pretenses or divulged without an individual's knowledge or consent.
jeer will not be made public or shared with others without the authorization of the subject. A breach of confidentiality occurs when the researcher, directly or indirectly, allows access to the raw data of a study. This could lead to identification of the subject's identity, and violation of the right to autonomy. For example, sharing research data about an employee's substance abuse with the employer could lead to loss of employment. Breaches of confidentiality can result in emotional and/or social harm (Burns, 1987) .
Anonymity exists if subjects' identity cannot be linked with their responses, even by the investigator. To maintain subject anonymity, questionnaires should have code numbers rather than any information that will reveal the identity of the subject. If follow up of subjects is needed, names should be kept in a separate place from the research instruments, under lock and key.
All data should be group analyzed to avoid individual subject identity. When publishing study results, pseudonyms or general descriptions to report aggregate data should be used to protect subjects. For example, reporting that data were collected from a specific hospital or industrial setting without their permission virtually would identify the data source. Rather, giving a geographic location such as "data were collected from a large hospital (or pharmaceutical firm) in the southeastern United States" would be necessary to maintain anonymity.
Right to Protection from Harm
Protecting persons from harm is based on the ethical principle of nonmaleficence, which is embodied in most ethical codes. This same principle applies to researchers in that study subjects should be protected from physical or mental discomfort and harm. Reynolds (1972) described five types of studies related to harm or the risk of harm, ranging from no anticipated effects to permanent damage:
• Studies involving reviews of records or reports without any interaction with the researcher generally have no anticipated harmful effects on subjects. However, a potential risk that privacy might not be protected always exists.
.Stud~iliM inw~e rem~rary discomfort for the subject, in which the discomfort encountered is similar to what the subject would experience in daily life and ceases with termination of the study, are described as minimal risk studies. Completion of questionnaires or participating in interviews that might produce mild stress associated with responding to certain questions, or cause fatigue or muscle tension, usually involves minimal risk for a subject. • In studies that involve unusual levels of temporary discomfort, the pain or discomfort usually persists for some time after the termination of the research project. For example, the physical discomfort that might accompany the drawing of blood gases or studies that require subjects to relive a harmful experience such as an assault or battering often may involve unusuallevels of temporary pain. 
Elements of Informed Consent
Introduction of Research Activities and Purposes.
Statements indicating that a study is to be conducted, the purposes of and procedures involved in the research, including time commitment and measurements involved, and the expected duration of the subject's participation should be provided.
Selection of Research Subjects.
Subjects should be told how and why they were selected to participate (i.e., belong to a specific organization, have a certain disease or exposure).
Description of Risks or Discomfort.
A complete description of all anticipated risks should be given to the subjects and an indication if medical treatment might be needed as a result of the experiment.
Description of Benefits.
All benefits either to the subjects or society should be addressed, including financial rewards.
Disclosure of Alternatives.
Any alternative procedure or course of treatment that might exist and benefit the subject must be disclosed. For example, if another drug or type of procedure is available, the subject should be given this information.
6. Confidentiality. A statement describing the extent to which confidentiality of records/responses will be maintained and assurances that anonymity will be guarded should be given.
7. Offer to Answer Questions. Prospective subjects need to know whom to contact if they have questions about the research, their rights as study participants, and who to call in case of injury.
Voluntary Participation.
A statement indicating that participation is entirely voluntary, refusal to participate will not result in any penalty or loss of benefits to which the subject is otherwise entitled, and that the subjects can withdraw at any time without penalty should be provided. Researchers do have the right, however, to ask subjects if they think they will be able to complete the study.
sexual abuse, or other emotionally disturbing events, may pose significant risks for the subjects socially, mentally, physically, and economically if loss of employment becomes a result of the emotional threat brought on by the research. • Any type of research study that would result in permanent damage is highly questionable, regardless of the benefits derived. This is particularly true since the benefits are usually to other people and not the subject. Extreme examples of these types of studies include the highly unethical abuses of human subjects in the Nazi war experiments or Tuskegee study cited earlier.
Informed Consent
The process of obtaining informed consent involves transmitting essential information and content related to the study purpose and procedures in a form the study subjects can comprehend. The subjects' agreement to participate in the study must be obtained also without undue inducement, force, or coercion. The DHHS (1981) identified basic elements of informed consent ( Figure  1 ). Relevant information is usually provided in a letter to prospective study subjects.
It is important that the researcher take the time to develop an appropriate written informed consent statement using lay terminology, not professional jargon, when appropriate (Polit, 1987) . For ease of reading and logical flow of thought, the consent form can be organized as follows: introduction and statement of study purpose; procedural aspects of the study; description of potential risks, discomfort, and potential benefits; alternative courses of action, if available; statement about confidentiality of information and/or anonymity; the right to refuse to participate in or withdraw from the study; and an offer to answer questions. Figure 2 shows an example of a consent form. For subjects with diminished autonomy, the researcher must make every effort to present all information at the level at which subjects can understand the material. In addition, the researcher must present essential information for consent to the legally authorized representative of the prospective subject (Levine, 1981) .
RISK-BENEFIT
Concern for protecting human re-search subjects has been extended beyond research that threatens bodily harm, such as drug toxicity or discomfort, to include research that threatens a subject's self-esteem, self-worth, values, and privacy. The risks of anxiety, embarrassment, or other stressors must be weighed against the benefits in any study, and the risk-benefit ratio must be dis-Signature _
Cardiovascular Risk Factors Consent Form
I understand that this is a study of cardiovascular risk factors in working women to see if planned instructional and counseling experiences have an impact on behaviors. In this study, I will have a free health examination which will include the following: blood pressure, cholesterol, height and weight, and measurement ofthe skin fold of the upper arm. In addition, I will answer some questions about health and the examination and interviews will be conducted during regular work hours, and will take approximately 1 hour. I further understand that there is little risk to participating in this study. There may be slight discomfort during the cholesterol measurement, which uses a small finger prick to obtain a drop of blood; the finger may have a very small bruise or be sore for a few minutes. The finger prick will be done by nurses who are experienced with the technique. As a benefit of participating, I will receive information about the risk for possibly developing heart disease.
I understand that all information obtained from the examination and interviews will be confidential; information will be collected using code numbers as identifiers. I realize that I may choose not to participate in the study or I may withdraw at any time without fear of penalty. I am free to contact the researcher at any time if I have questions. closed clearly to all research subjects before they agree to participate.
The second issue in calculating the risk-benefit requires that risks to research subjects be justified by potential benefit to them, in the case of clinical research, or to society in the knowledge produced. The benefits, in short, should exceed the risks. Even then, the risks to an individual to exposure to experimental drugs which may result in horrendous side effects such as bleeding, hepatorenal damage, hair loss, etc. may not always be justified by advancing society's knowledge (Wilson, 1985) .
The risk-benefit ratio continues as a primary objective standard by which to judge the ethics of certain research procedures. Calculation involves naming the benefits and weighing them, as well as considering two questions: "How important is the research?" and "How serious are the risks to human subjects?"
In all cases of research, the researchers must ethically balance the potential benefits with the associated risks in the study. The researcher must assess the type and degree of all risks the subjects might assume and identify the potential benefits that might be received. These may include, for example, improvement in physical condition, better emotional health, reduction in injuries, and increases in knowledge about the phenomena under study.
Once the benefits and risks are assessed the researcher must try to maximize the benefits and minimize the risks by making study design changes, if necessary. If further reduction of risks cannot be achieved, the researcher must be able to justify their existence. However, if the risks clearly outweigh the benefits, the study should be rejected and aborted.
To provide assurances that subjects' rights are not violated, many institutions or organizations (and all who receive research funding from the U.S. Department of Health and Human Services) have in place Institutional Review Boards, commonly referred to as IRBs. The IRB is composed of at least five members with scientific expertise who review research activities conducted by the institution and the investigations therein. The IRB's purpose is to counsel regarding the safeguard of the rights and welfare of human subjects, and approve all research to be conducted. General informed consent, as shown in Figure 1 , is required by IRBs for research approval (U.S. DHHS, 1987) .
CONCLUSION
When human beings are used as research subjects, which is generally the case in nursing research, great care must be taken to ensure that their rights are protected. As scientists and researchers, nurses must be aware of not only the legal parameters affecting the nurse-client relationship, but also the responsibility and accountability for the ethical protection of research subjects.
Research subjects have basic rights related to the ethical principles of autonomy, nonmaleficence, beneficence, and justice. Inherent within these principles, subjects have the right to respect and choice, freedom from harm, promotion of benefits, and the right to be treated fairly and without discrimination. Ethics in research is a complex phenomenon when one is engaged in scientific inquiry for the betterment of society. However, the safeguards that exist for study subjects also protect researchers and will enable them to develop sensitivity to ethical considerations.
The use of coercion, such as a threat of harm, or excessive • reward to influence subject participation in research is unethical.
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The benefits and risks related to participating in a research • study should be disclosed to all subjects. In order to conduct the study, the benefits should exceed the risks.
Research subjects have the right to self-determination, informed consent, confidentiality and privacy, and freedom from harm.
